Ian Frank

This inventor holds 21 USPTO granted patents and 5 published patent applications and 1 EPO patent, primarily in Cancer Immunotherapy. Top assignee: Iovance Biotherapeutics, Inc.. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ian Frank. Retrieved from https://idiyas.com/inventor/ian-frank

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 5)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 2.0

ph-index = 5

Forward Citations = 119(Granted Patents)

Company Filing History:

21 out of 110

Iovance Biotherapeutics, Inc.

patents

Years Active: 2019-2025

Loading Chart...

Areas of Expertise:

Cryopreservation

Tumor Infiltrating Lymphocytes

Immunotherapy

Cancer Treatment

Cell Therapy

Tumor Restimulation

Lymphocyte Activation

T Cell Therapy

Oncology

Biotechnology

Cancer Research

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12188048 - Restimulation of cryopreserved tumor infiltrating lymphocytes (2025-01-07),

2. 11975028 - Restimulation of cryopreserved tumor infiltrating lymphocytes (2024-05-07),

3. 11969444 - Restimulation of cryopreserved tumor infiltrating lymphocytes (2024-04-30),

4. 11865140 - Restimulation of cryopreserved tumor infiltrating lymphocytes (2024-01-09),

5. 11857573 - Restimulation of cryopreserved tumor infiltrating lymphocytes (2024-01-02),

6. 11369637 - Restimulation of cryopreserved tumor infiltrating lymphocytes (2022-06-28),

7. 11364266 - Restimulation of cryopreserved tumor infiltrating lymphocytes (2022-06-21),

8. 11351199 - Restimulation of cryopreserved tumor infiltrating lymphocytes (2022-06-07),

9. 11351198 - Restimulation of cryopreserved tumor infiltrating lymphocytes (2022-06-07),

10. 11351197 - Restimulation of cryopreserved tumor infiltrating lymphocytes (2022-06-07),

11. 11344581 - Restimulation of cryopreserved tumor infiltrating lymphocytes (2022-05-31),

12. 11344580 - Restimulation of cryopreserved tumor infiltrating lymphocytes (2022-05-31),

13. 11311578 - Restimulation of cryopreserved tumor infiltrating lymphocytes (2022-04-26),

14. 11304980 - Restimulation of cryopreserved tumor infiltrating lymphocytes (2022-04-19),

15. 11266694 - Restimulation of cryopreserved tumor infiltrating lymphocytes (2022-03-08),

Title: The Innovative Mind of Ian Frank: Driving Advancements in Biotechnology

Introduction: Ian Frank, a prolific inventor hailing from Tampa, FL, has made significant contributions to the field of biotechnology. With a remarkable portfolio of 20 patents, his groundbreaking work has been pivotal in advancing the realm of cancer immunotherapy.

Latest Patents: Ian Frank's latest patents focus on the restimulation of cryopreserved tumor infiltrating lymphocytes. These patents outline methods for re-stimulating TIL populations to enhance their phenotype and metabolic health, thereby improving the efficacy of TIL infusion post-re-stimulation.

Career Highlights: Ian Frank's journey as an inventor has been marked by relentless innovation and a drive for excellence. Having worked at renowned companies such as Iovance Biotherapeutics, Inc. (formerly known as Iovante Biotherapeutics, Inc.), he has honed his expertise in developing cutting-edge solutions for complex medical challenges.

Collaborations: Throughout his career, Ian Frank has collaborated closely with esteemed professionals in the field. One of his notable coworkers is Michael T. Lotze, with whom he has synergized to create impactful advancements in biotechnology. Their combined efforts have led to the development of pioneering solutions with far-reaching implications.

Conclusion: Ian Frank's dedication to innovation and his relentless pursuit of scientific excellence have solidified his position as a trailblazer in the field of biotechnology. His patents stand as a testament to his ingenuity and unwavering commitment to driving progress in the fight against cancer. Ian Frank's contributions continue to inspire and shape the future of medical innovation, making him a true luminary in the realm of biotechnology.

Profile summary based on public USPTO records.